NCT00996047

S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers

Study Contact:

Study Phase:

Recruitment Status:

COMPLETED

NCT ID:

NCT00996047

Principal Investigator:

Study Type:

OBSERVATIONAL

Official Title:

S9007, Cytogenetic Studies in Leukemia Patients

Summary

RATIONALE: Studying samples of bone marrow and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment.

PURPOSE: This research study is looking at bone marrow and blood samples from patients with leukemia or other hematopoietic cancers.

Eligibility

DISEASE CHARACTERISTICS:

* Registered on one of the following Southwest Oncology Group treatment protocols:

* SWOG-8326, SWOG-8600, SWOG-8612, SWOG-9034, SWOG-9108, OR any new leukemia protocol approved as of 1990

PATIENT CHARACTERISTICS:

* Not specified

PRIOR CONCURRENT THERAPY:

* See Disease Characteristics

Disease(s) and\or Condition(s)

Leukemia

Myelodysplastic Syndromes

Myelodysplastic/Myeloproliferative Neoplasms

Primary Purpose

Intervention/Treatment

- Type: GENETIC
- Name: cytogenetic analysis
- Description:
- Arm Group Labels:
- Type: GENETIC
- Name: fluorescence in situ hybridization
- Description:
- Arm Group Labels:

Sponsor

SWOG Cancer Research Network